Bernd Bohrmann
10Patents
5h-index
25Co-inventors
62Inventor score
Filing activity: Feb 20, 2003 → Dec 22, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7794719B2 | Anti-amyloid β antibodies | Human Necessities | 73 | Expired |
| US8609097B2 | Use of an anti-Tau pS422 antibody for the treatment of brain diseases | Chemistry; Metallurgy | 25 | Active |
| US9290567B2 | Use of an anti-Tau pS422 antibody for the treatment of brain diseases | Chemistry; Metallurgy | 23 | Active |
| US8329886B2 | Nucleic acid molecules encoding anti-amyloid beta antibodies | Human Necessities | 20 | Active |
| US8216577B2 | Anti-Aβ antibodies and their use | Human Necessities | 12 | Active |
| US9562091B2 | Humanized anti-Tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9272031B2 | Antibodies against amyloid beta 4 with glycosylation in the variable region | Chemistry; Metallurgy | 2 | Active |
| US8906370B2 | Antibodies against amyloid beta 4 with glycosylation in the variable region | Chemistry; Metallurgy | 1 | Active |
| US10465000B2 | Humanized anti-Tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US10308710B2 | Humanized anti-Tau(pS422) antibodies and methods of use | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.